Prognostic significance of QRS duration and morphology

Cardiology Journal

Volumn 18, Issue 1, 2011, Pages 8-17

  Brenyo, Andrew ^a   Zarȩba, Wojciech ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Left bundle branch block; Mortality; Prognosis; QRS duration

Indexed keywords

AMIODARONE; CAPTOPRIL; VALSARTAN;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DRUG EFFICACY; ELECTROCARDIOGRAM; HEART DEATH; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART RATE; HEART RATE VARIABILITY; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; QRS COMPLEX; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SUDDEN DEATH;

ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART DISEASES; HEART RATE; HUMANS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TIME FACTORS;

EID: 79951494879     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Rabkin SW, Mathewson FL, Tate RB. The electrocardiogram in apparently healthy men and the risk of sudden death. Br Heart J, 1982; 47: 546-552.
2. Schinkel AF, Elhendy A, van Domburg RT et al. Prognostic significance of QRS duration in patients with suspected coronary artery disease referred for noninvasive evaluation of myocardial ischemia. Am J Cardiol, 2009; 104: 1490-1493.
3. Elhendy A, Hammill SC, Mahoney DW, Pellikka PA. Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol, 2005; 96: 1082-1088.
4. Petrina M, Goodman SG, Eagle KA. The 12-lead electrocardiogram as a predictive tool of mortality after acute myocardial infarction: Current status in an era of revascularization and reperfusion. Am Heart J, 2006; 152: 11-18.
5. Brilakis ES, Wright RS, Kopecky SL, Reeder GS, Williams BA, Miller WL. Bundle branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol, 2001; 88: 205-209.
6. Hindman MC, Wagner GS, JaRo M et al. The clinical significance of bundle branch block complicating acute myocardial infarction. 1. Clinical characteristics, hospital mortality, and one-year follow-up. Circulation, 1978; 58: 679-688.
7. Nimetz AA, Shubrooks SJ Jr, Hutter AM Jr, DeSanctis RW. The significance of bundle branch block during acute myocardial infarction. Am Heart J, 1975; 90: 439-444.
8. Hathaway WR, Peterson ED, Wagner GS et al. Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. JAMA. 1998; 279: 387-391.
9. Wong CK, Gao W, Stewart RA, French JK, Aylward PE, White HD. Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: Results from the Hirulog and Early Reperfusion or Occlusion-2 trial. Heart, 2009; 95: 276-282.
10. Bauer A, Watanabe MA, Barthel P, Schneider R, Ulm K, Schmidt G. QRS duration and late mortality in unselected post-infarction patients of the revascularization era. Eur Heart J, 2006; 27: 427-433.
11. Guerrero M, Harjai K, Stone GW et al. Comparison of the prognostic effect of left versus right versus no bundle branch block on presenting electrocardiogram in acute myocardial infarction patients treated with primary angioplasty in the primary angioplasty in myocardial infarction trials. Am J Cardiol, 2005; 96: 482-488.
12. Yerra L, Anavekar N, Skali H et al. Association of QRS duration and outcomes after myocardial infarction: The VALIANT trial. Heart Rhythm, 2006; 3: 313-316.
13. Solomon SD, Zelenkofske S, McMurray JJ et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med, 2005; 352: 2581-2588.
14. Hohnloser SH, Kuck KH, Dorian P et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med, 2004; 351: 2481-2488.
15. Coronary artery surgery study (CASS): A randomized trial of coronary artery bypass surgery. Survival data. Circulation, 1983; 68: 939-950.
16. Zimetbaum PJ, Buxton AE, Batsford W et al. Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial. Circulation, 2004; 110: 766-769.
17. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005; 352: 225-237.
18. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 2002; 346: 877-883.
19. Buxton AE, Sweeney MO, Wathen MS et al. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators. J Am Coll Cardiol, 2005; 46: 310-316.
20. Dhar R, Alsheikh-Ali AA, Estes NA 3rd et al. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm, 2008; 5: 807-813.
21. Goldenberg I, Vyas AK, Hall WJ et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol, 2008; 51: 288-296.
22. Garikipati NV PV, Adhaduk M et al. Risk stratification of ICD patients with ischemic cardiomyopathy: Do clinical trial results apply in the "real world"? Circulation, 2010; A16147.
23. Poll DS, Marchlinski FE, Falcone RA, Josephson ME, Simson MB. Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: Relationship to sus tained ventricular tachyarrhythmias. Circulation, 1985; 72: 1308-1313.
24. Mancini DM, Wong KL, Simson MB. Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation, 1993; 87: 1083-1092.
25. Grimm W, Christ M, Bach J, Muller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation, 2003;108: 2883-2891.
26. Kadish A, Dyer A, Daubert JP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med, 2004; 350: 2151-2158.
27. Hombach V, Merkle N, Torzewski J et al. Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J, 2009; 30: 2011-2018.
28. Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, 2004; 350: 2140-2150.
29. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005; 352: 1539-1549.
30. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med, 2001; 344: 873-880.
31. Jeevanantham V, Daubert JP, Zareba W. Cardiac resynchronization therapy in heart failure patients: An update. Cardiol J, 2009; 16: 197-209.
32. Zareba W, Zareba KM. Which patients with chronic heart failure should be referred for CRT-D implantation? Practical implications of current clinical research. Pol Arch Med Wewn, 2010; 120: 95-102.
33. Baldasseroni S, Opasich C, Gorini M et al. Left bundle-branch block is associated with increased one-year sudden and total mortality rate in 5,517 outpatients with congestive heart failure: A report from the Italian network on congestive heart failure. Am Heart J, 2002; 143: 398-405.
34. Barsheshet A, Leor J, Goldbourt U et al. Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure. Am J Cardiol, 2008; 101: 1303-1308.
35. Iler MA, Hu T, Ayyagari S et al. Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy. Am J Cardiol, 2008; 101: 359-363.
36. Adelstein EC, Saba S. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. Am J Cardiol, 2009; 103: 238-242.
37. Wokhlu A, Rea RF, Asirvatham SJ et al. Upgrade and de novo cardiac resynchronization therapy: Impact of paced or intrinsic QRS morphology on outcomes and survival. Heart Rhythm, 2009; 6: 1439-1447.
38. Moss AJ, Hall WJ, Cannom DS et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med., 2009; 361: 1329-1338.
39. Zareba W KH, Cygankiewicz I et al. Effectiveness of cardiac resynchronization therapy by QRS morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation, 2011 (in press).
40. Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol, 2008; 52: 1834-1843.
41. Tang AS, Wells GA, Talajic M et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med, 2010; 363: 2385-2395.
42. Zare{ogonek}ba W. Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure. Cardiol J, 2010; 17: 543-548.
43. Barsheshet A GI, Moss AJ et al. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J, 2011 (in press).